ZymoGenetics Reviews

3.7
Rating Trends
Recommend to a friend
Approve of CEO
(no image)
Jeremy Levin
1 Rating
  • Review

    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    • Comp & Benefits
    • Senior Management
    Current Employee - Research Associate in Seattle, WA
    Current Employee - Research Associate in Seattle, WA

    I have been working at ZymoGenetics full-time (More than 3 years)

    Recommends
    Positive Outlook
    No opinion of CEO
    Recommends
    Positive Outlook
    No opinion of CEO

    Pros

    Was a great place to work. The company and upper management really supported growth. Company has a great tuition reimbursement opportunity for those that want to take advantage of it.

    Cons

    There was some favoritism, but may not be company wide. Each group was different.


ZymoGenetics Interviews

Interview Experience

Interview Experience

50%
50%
0%

Getting an Interview

Getting an Interview

33%
33%
33%

Interview Difficulty

3.0
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    No Offer
    Neutral Experience
    Average Interview

    Application

    I applied online. The process took 2 weeksinterviewed at ZymoGenetics in October 2014.

    Interview

    HR is outsourced to Bristol Meyers Squib (parent company) recruiter in New Jersey and that is where my phone screen came from and then the later e-mail follow-up invitation to interview and schedule of interviewers. The interview was held at the new Bothell Manufacturing location which had only received Occupancy Permit a couple weeks earlier so the construction staff outnumbered the Zymo Staff and the un-occupied (non-Zymo) portion of the building was being "squatted in" with the landlord's permission for preliminary move-in purposes. I walked into the front on the building where a Security Guard was posted and was told to go to the back of the building. There wasn't anyone or any sign as to what doors at the back were for what. As I continued around the building, I saw someone and asked where I could find Zymo for an interview. They walked me into the Construction Office area and eventually I was hooked up with my first interviewer. There was no office obviously available for interviewing but during our second trip upstairs we found a room with two chairs and a desk which we used. Two of the six people I interviewed with were phone numbers which I had to call with my own phone. One of them was with the same New Jersey recruiter who really didn't have anything extra to add or ask different from the phone screen. Although I thought I interviewed well and have done the exact same job more than once in other BioTechs in the area, I was not contacted at all after the interview. I did call and ask the other phone interviewer (local HR) if I could find out my status in the interviewing process 3 weeks after, and was told I would be contacted. I was not contacted.

    Interview Questions

    • No out of the ordinary questions at all. Only one interviewer stuck to the script of asking Behavioral Questions like the recruiter had told me would be asked. I got the impression that the corporate controllers had set a very aggressive date for first start up run of the operation and that there was a bit of a scramble going on trying to make it.   Answer Question

ZymoGenetics Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.zymogenetics.com
Headquarters Seattle, WA
Size 150 to 499 Employees
Founded 1981
Type Subsidiary or Business Segment
Industry Biotech & Pharmaceuticals
Revenue Unknown / Non-Applicable per year
Competitors Baxter, Pfizer, Ethicon

ZymoGenetics has proteins on its plate. The firm culls genomics databases to indentify and develop protein-based drugs targeting a variety conditions. Its sole commercial product, RECOTHROM (rThrombin), controls bleeding during surgery. Unlike existing forms of thrombin, RECOTHROM is derived from recombinant proteins instead of animal or human blood, which can trigger adverse reactions. The lead candidate in ZymoGenetics' research and development pipeline is an antiviral therapy to treat hepatitis C. The company is a wholly owned subsidiary of Bristol-Myers Squibb ... More

Work at ZymoGenetics? Share Your Experiences

ZymoGenetics

 
Click to Rate
or